2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->6)-[alpha-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside(CAS: 130603-71-3)

This compound falls under various regulatory guidelines, including GHS classification, REACH regulations, and FDA/EPA requirements. It must be labeled according to GHS guidelines, registered under REACH, and handled in compliance with EPA and FDA regulations for chemical substances. Specific safety data sheets (SDS) should be prepared and available for all handling and storage purposes.

Alternatives include using isomers or analogs such as 2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->6)-[alpha-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside. Common alternative reagents like diethyl ether or other solvents may be used in the synthesis process. These alternatives can provide similar functionalities but with different chemical properties.

The market trend for this compound is growing due to its potential applications in natural product chemistry and medicine. Research is focusing on its biological activities, such as antioxidant and anti-inflammatory properties. Market demand is increasing as more studies explore its therapeutic potential, though its current use is primarily in laboratory research and specialized applications.

Waste containing this compound should be collected in compatible containers and stored in a secure and well-ventilated area. Incineration or professional waste disposal services are recommended for handling. Environmental protection measures include ensuring no spills and proper containment to prevent contamination. Always follow local and federal regulations for hazardous waste disposal.